Presentation NY Valves 2025 One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement Presenter: Isaac George June 27, 2025
Presentation NY Valves 2025 Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies Presenter: Guido Ascione June 27, 2025
Presentation NY Valves 2025 Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry Presenter: Santiago Garcia June 27, 2025
Presentation NY Valves 2025 Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Presenter: Gilbert H. L. Tang June 27, 2025
Presentation NY Valves 2025 Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries Presenter: Julio Echarte Morales June 26, 2025
Presentation NY Valves 2025 Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study Presenter: Suzanne V. Arnold June 26, 2025
Presentation NY Valves 2025 TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement Presenter: Paul A. Grayburn June 26, 2025
Presentation NY Valves 2025 Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER Presenter: Matthew J. Price June 26, 2025
Presentation NY Valves 2025 Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position Presenter: Santiago Garcia June 25, 2025
Presentation NY Valves 2025 TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant Presenter: Shinichi Fukuhara June 25, 2025
Presentation NY Valves 2025 Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial Presenter: Sammy Elmariah June 25, 2025
Presentation NY Valves 2025 Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial Presenter: Allan Schwartz June 25, 2025
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Conference News NY Valves 2024 Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR Michael O'Riordan June 11, 2024
News Conference News NY Valves 2024 Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR Michael O'Riordan June 10, 2024
News Conference News NY Valves 2024 AV Block Common After Transcatheter Tricuspid Valve Replacement for TR Michael O'Riordan June 07, 2024
Presentation NY Valves 2024 Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States Presenter: Tsuyoshi Kaneko June 07, 2024
Presentation NY Valves 2024 Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis Presenter: Sebastian Ludwig June 07, 2024
Presentation NY Valves 2024 Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients Presenter: Anita W. Asgar June 07, 2024
Presentation NY Valves 2024 Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk Presenter: Steven J. Yakubov June 07, 2024